An in-vivo model to interrogate the transition from acute to chronic inflammation.

This study describes the modulation of the rodent foreign body giant cell (FBGC) response to subcutaneously implanted, biodegradable poly(lactide-co-glycolide)/calcium phosphate (PLGA/CaP) composites by application of a thin surface coat of calcium phosphate. Macroporous PLGA/CaP composite scaffolds, with interconnecting macroporosity, were half coated with a 3mm thick layer of CaP by immersion in simulated body fluid. Half-coated scaffolds were implanted subcutaneously in the dorsum of male Wistar rats for 1, 4 and 8 weeks. Specimens were embedded in paraffin and tissue sections evaluated by light microscopy with particular reference to the FBGC response. Histomorphometry revealed that FBGCs were in contact with 6% (+/- 3.5%) of the uncoated half, at 1 week, but no FBGCs were seen on the coated half. By 4 weeks, FBGCs were seen on both the uncoated and coated halves of the scaffolds with 87% (+/-10%) and 36% (+/-4%) FBGC/polymer contact respectively. By 8 weeks these FBGC contact percentages had risen to 97% (+/-0.45%) in the case of the uncoated halves of scaffolds, but decreased to 22% (+/-4%) in the case of the CaP-coated halves. Thus the CaP coating abrogated the FBGC response to the underlying polymer. Such a model may prove useful in providing an experimental system whereby both the mechanisms of biocompatibility and the transition from acute to chronic inflammation could be interrogated.

[1]  L. Guan,et al.  Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold. , 2004, Journal of biomedical materials research. Part A.

[2]  Choll W. Kim,et al.  Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation. , 2004, Journal of biomedical materials research. Part A.

[3]  James M. Anderson,et al.  Inhibition of macrophage development and foreign body giant cell formation by hydrophilic interpenetrating polymer network. , 2004, Journal of biomedical materials research. Part A.

[4]  G. Mccarthy,et al.  Basic calcium phosphate deposition in the joint: a potential therapeutic target in osteoarthritis , 2004, Current opinion in rheumatology.

[5]  J. Santerre,et al.  Changes in macrophage function and morphology due to biomedical polyurethane surfaces undergoing biodegradation , 2004, Journal of cellular physiology.

[6]  Y. Leng,et al.  TEM study of calcium phosphate precipitation on HA/TCP ceramics. , 2003, Biomaterials.

[7]  J. Hamilton.  Nondisposable materials, chronic inflammation, and adjuvant action , 2003, Journal of leukocyte biology.

[8]  John E. Davies,et al.  Fabrication of Precise Cylindrical Three-Dimensional Tissue Engineering Scaffolds for In Vitro and In Vivo Bone Engineering Applications , 2003, The Journal of craniofacial surgery.

[9]  K. Ishihara,et al.  Reduction of surface-induced inflammatory reaction on PLGA/MPC polymer blend. , 2002, Biomaterials.

[10]  F Moussy,et al.  In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. , 2002, Journal of biomedical materials research.

[11]  J M Anderson,et al.  Protein and surface effects on monocyte and macrophage adhesion, maturation, and survival. , 2002, Journal of biomedical materials research.

[12]  J M Anderson,et al.  Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. , 2002, Cytokine.

[13]  J. Babensee,et al.  Interconnections between Inflammatory and Immune Responses in Tissue Engineering , 2002, Annals of the New York Academy of Sciences.

[14]  C. Blitterswijk,et al.  Influence of ionic strength and carbonate on the Ca-P coating formation from SBF×5 solution , 2002 .

[15]  James M. Anderson,et al.  β1 and β2 Integrins Mediate Adhesion during Macrophage Fusion and Multinucleated Foreign Body Giant Cell Formation , 2002 .

[16]  W. Kao,et al.  In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides: the role of RGD and PHSRN domains. , 2001, Biomaterials.

[17]  J W Eaton,et al.  Molecular basis of biomaterial-mediated foreign body reactions. , 2001, Blood.

[18]  C. M. Agrawal,et al.  Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. , 2001, Journal of biomedical materials research.

[19]  O. Böstman,et al.  Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. , 2000, Biomaterials.

[20]  J. Janatova,et al.  Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. , 2000, ASAIO journal.

[21]  A. Vignery,et al.  Osteoclasts and giant cells: macrophage–macrophage fusion mechanism , 2000, International journal of experimental pathology.

[22]  J M Anderson,et al.  Adsorbed serum proteins responsible for surface dependent human macrophage behavior. , 2000, Journal of biomedical materials research.

[23]  E. Sudmann,et al.  Biocompatibility and effect on osteogenesis of poly(ortho ester) compared to poly(DL-lactic acid). , 2000, Journal of biomedical materials research.

[24]  C. V. van Blitterswijk,et al.  Biomimetic calcium phosphate coatings on Ti6AI4V: a crystal growth study of octacalcium phosphate and inhibition by Mg2+ and HCO3-. , 1999, Bone.

[25]  K E Healy,et al.  Designing Biomaterials to Direct Biological Responses , 1999, Annals of the New York Academy of Sciences.

[26]  James M. Anderson,et al.  Disruption of filamentous actin inhibits human macrophage fusion , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  H. Jun,et al.  The Role of Macrophages in T Cell–mediated Autoimmune Diabetes in Nonobese Diabetic Mice , 1999, The Journal of experimental medicine.

[28]  L. de Leij,et al.  Inhibition of the tissue reaction to a biodegradable biomaterial by monoclonal antibodies to IFN-gamma. , 1998, Journal of biomedical materials research.

[29]  B. Eppley.  Use of a Resorbable Fixation Technique for Maxillary Fractures , 1998, The Journal of craniofacial surgery.

[30]  C. M. Agrawal,et al.  Technique to control pH in vicinity of biodegrading PLA-PGA implants. , 1997, Journal of biomedical materials research.

[31]  J. Möst,et al.  Formation of multinucleated giant cells in vitro is dependent on the stage of monocyte to macrophage maturation. , 1997, Blood.

[32]  A. Hiltner,et al.  Vitamin E as an antioxidant for poly(etherurethane urea): in vivo studies. Student Research Award in the Doctoral Degree Candidate Category, Fifth World Biomaterials Congress (22nd Annual Meeting of the Society for Biomaterials), Toronto, Canada, May 29-June 2, 1996. , 1996, Journal of biomedical materials research.

[33]  N. Udupa,et al.  Biodegradable Injectable Implant Systems for Long Term Drug Delivery Using Poly (Lactic‐co‐glycolic) Acid Copolymers , 1996, The Journal of pharmacy and pharmacology.

[34]  J. Eaton,et al.  Molecular determinants of acute inflammatory responses to biomaterials. , 1996, The Journal of clinical investigation.

[35]  Steffen Jung,et al.  Macrophages in T cell line‐mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats , 1995, Clinical and experimental immunology.

[36]  T. Yamamuro,et al.  Apatite coated on organic polymers by biomimetic process: improvement in its adhesion to substrate by glow-discharge treatment. , 1995, Journal of biomedical materials research.

[37]  J M Anderson,et al.  Inflammatory response to implants. , 1988, ASAIO transactions.

[38]  Jerome A Werkmeister,et al.  Collagen-hydroxyapatite composite prepared by biomimetic process. , 2004, Journal of biomedical materials research. Part A.

[39]  J. Babensee,et al.  Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering. , 2004, Biomaterials.

[40]  J. Duffield.  The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.

[41]  James M. Anderson,et al.  Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. , 2002, The American journal of pathology.

[42]  J. Anderson,et al.  Biomaterial biocompatibility and the macrophage. , 1984, Biomaterials.